1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Republic of Korea 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Actual,
2003-2017 11
3.3 Diabetes Care Devices Market, Republic of Korea, Revenue Mix ($m), 2010 12
3.4 Diabetes Care Devices Market, Republic of Korea, Category Contribution (%),
2010 13
3.5 Diabetes Care Devices, Republic of Korea, Category Volume (Units), 2003-2017
19
3.6 Diabetes Care Devices, Republic of Korea, Company share (2009-2010) 22
4 Glucose Monitoring In Republic of Korea 24
4.1 Glucose Monitoring, Market Segmentation 24
4.2 Glucose Monitoring Market, Republic of Korea, Revenue Mix ($m), 2010 25
4.3 Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2010
26
4.4 Glucose Monitoring Overall Revenue (2003-2017) 27
4.4.1 Blood Glucose Meters Revenue (2003-2017) 31
4.5 Glucose Monitoring Overall Volume (2003-2017) 33
4.5.1 Blood Glucose Meters Volume (2003-2017) 37
4.6 Glucose Monitoring Average Price (2003-2017) 39
4.7 Glucose Monitoring Distribution Share (2009-2010) 40
4.8 Glucose Monitoring, Republic of Korea, Company share (2009-2010) 41
5 Insulin Delivery In Republic of Korea 43
5.1 Insulin Delivery, Market Segmentation 43
5.2 Insulin Delivery Market, Republic of Korea, Revenue Mix ($m), 2010 44
5.3 Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2010
45
5.4 Insulin Delivery Overall Revenue (2003-2017) 46
5.4.1 Insulin Pens Revenue (2003-2017) 50
5.4.2 Insulin Pumps Revenue (2003-2017) 54
5.5 Insulin Delivery Overall Volume (2003-2017) 56
5.5.1 Insulin Pens Volume (2003-2017) 60
5.5.2 Insulin Pumps Volume (2003-2017) 64
5.6 Insulin Delivery Average Price (2003-2017) 66
5.7 Insulin Delivery Distribution Share (2009-2010) 67
5.8 Insulin Delivery, Republic of Korea, Company share (2009-2010) 68
6 Overview of Key Companies in Republic of Korea Diabetes Care Devices Market 70
6.1 F. Hoffmann-La Roche Ltd. 70
6.1.1 Company Overview 70
6.1.2 Share in the Republic of Korea Diabetes Care Devices Market 70
6.2 LifeScan, Inc. 71
6.2.1 Company Overview 71
6.2.2 Share in the Republic of Korea Diabetes Care Devices Market 71
6.3 Abbott Laboratories 72
6.3.1 Company Overview 72
6.3.2 Share in the Republic of Korea Diabetes Care Devices Market 72
6.4 Novo Nordisk A/S 73
6.4.1 Company Overview 73
6.4.2 Share in the Republic of Korea Diabetes Care Devices Market 73
6.5 Sanofi 74
6.5.1 Company Overview 74
6.5.2 Share in the Republic of Korea Diabetes Care Devices Market 74
6.6 Eli Lilly and Company 75
6.6.1 Company Overview 75
6.6.2 Share in the Republic of Korea Diabetes Care Devices Market 75
6.7 ARKRAY, Inc. 76
6.7.1 Company Overview 76
6.8 Bayer HealthCare AG 76
6.8.1 Company Overview 76
6.9 Terumo Corporation 76
6.9.1 Company Overview 76
6.10 Becton, Dickinson and Company 77
6.10.1 Company Overview 77
6.11 Apex Biotechnology Corp. 77
6.11.1 Company Overview 77
6.12 NIPRO CORPORATION 77
6.12.1 Company Overview 77
6.13 Medtronic, Inc. 78
6.13.1 Company Overview 78
6.14 Animas Corporation 78
6.14.1 Company Overview 78
7 Diabetes Care Devices Market Pipeline Products 79
8 Appendix 82
8.1 Definitions of Markets Covered in the Report 83
8.1.1 Diabetes Care Devices 83
8.2 Research Methodology 86
8.3 Secondary Research 86
8.4 Primary Research 87
8.5 Models 87
8.6 Forecasts 88
8.7 Expert Panels 88
8.8 GlobalData Consulting 88
8.9 Currency Conversion 89
8.10 Contact Us 89
8.11 Disclaimer 89
1.1 List of Tables
Table 1: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD
Actual, 2003-2017 11
Table 2: Diabetes Care Devices Market, Republic of Korea, Category Contribution
(%), 2010 13
Table 3: Diabetes Care Devices, Republic of Korea, Cross-Segment Analysis,
2003-2017 14
Table 4: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD
Actual, Historic, 2003-2010 16
Table 5: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD
Actual, Forecast, 2010-2017 18
Table 6: Diabetes Care Devices, Republic of Korea, Category Volume (Units),
2003-2017 19
Table 7: Diabetes Care Devices, Republic of Korea, Category Volume (Units),
Historic, 2003-2010 20
Table 8: Diabetes Care Devices, Republic of Korea, Category Volume (Units),
Forecast, 2010-2017 21
Table 9: Diabetes Care Devices, Republic of Korea, Company share by Revenue
($m), USD Actual, 2009-2010 23
Table 10: Glucose Monitoring Market, Republic of Korea, Segment Contribution
(%), 2010 26
Table 11: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 28
Table 12: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 30
Table 13: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Revenue ($m), USD Actual, Historic, 2003-2010 31
Table 14: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Revenue ($m), USD Actual, Forecast, 2010-2017 32
Table 15: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment,
Historic, 2003-2010 34
Table 16: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment,
Forecast, 2010-2017 36
Table 17: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Volume (Units), Historic, 2003-2010 37
Table 18: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Volume (Units), Forecast, 2010-2017 38
Table 19: Glucose Monitoring, Republic of Korea, Average Price ($), Historic,
2003-2010 39
Table 20: Glucose Monitoring, Republic of Korea, Average Price ($), Forecast,
2010-2017 39
Table 21: Glucose Monitoring, Republic of Korea, Distribution Share by Revenue
($m), USD Actual, 2009-2010 40
Table 22: Glucose Monitoring, Republic of Korea, Company share by Revenue ($m),
USD Actual 2009-2010 42
Table 23: Insulin Delivery Market, Republic of Korea, Segment Contribution (%),
2010 45
Table 24: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 47
Table 25: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 49
Table 26: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by
Sub-Segment, Historic, 2003-2010 51
Table 27: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by
Sub-Segment, Forecast, 2010-2017 53
Table 28: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue
($m), USD Actual, Historic, 2003-2010 54
Table 29: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue
($m), USD Actual, Forecast, 2010-2017 55
Table 30: Insulin Delivery, Republic of Korea, Volume (Units) by Segment,
Historic, 2003-2010 57
Table 31: Insulin Delivery, Republic of Korea, Volume (Units) by Segment,
Forecast, 2010-2017 59
Table 32: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment,
Historic, 2003-2010 61
Table 33: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 63
Table 34: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume
(Units), Historic, 2003-2010 64
Table 35: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume
(Units), Forecast, 2010-2017 65
Table 36: Insulin Delivery, Republic of Korea, Average Price ($), Historic,
2003-2010 66
Table 37: Insulin Delivery, Republic of Korea, Average Price ($), Forecast,
2010-2017 66
Table 38: Insulin Delivery, Republic of Korea, Distribution Share by Revenue
($m), USD Actual, 2009-2010 67
Table 39: Insulin Delivery, Republic of Korea, Company share by Revenue ($m),
USD Actual 2009-2010 69
Table 40: Diabetes Care Devices Market Pipeline Products 79
Table 41: USD to Local Currency, Republic of Korea, Average Actual Rate
2003-2010 89
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD
Actual, 2003-2017 11
Figure 3: Diabetes Care Devices Market, Republic of Korea, Revenue Mix ($m),
2010 12
Figure 4: Diabetes Care Devices Market, Republic of Korea, Category Contribution
(%), 2010 13
Figure 5: Diabetes Care Devices, Republic of Korea, Cross-Segment Analysis,
2003-2017 14
Figure 6: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD
Actual, Historic, 2003-2010 15
Figure 7: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD
Actual, Forecast, 2010-2017 17
Figure 8: Diabetes Care Devices, Republic of Korea, Category Volume (Units),
2003-2017 19
Figure 9: Diabetes Care Devices, Republic of Korea, Category Volume (Units),
Historic, 2003-2010 20
Figure 10: Diabetes Care Devices, Republic of Korea, Category Volume (Units),
Forecast, 2010-2017 21
Figure 11: Diabetes Care Devices, Republic of Korea, Company share (%), 2010 22
Figure 12: Glucose Monitoring, Market Segmentation 24
Figure 13: Glucose Monitoring Market, Republic of Korea, Revenue Mix ($m), 2010
25
Figure 14: Glucose Monitoring Market, Republic of Korea, Segment Contribution
(%), 2010 26
Figure 15: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 27
Figure 16: Glucose Monitoring, Republic of Korea, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 29
Figure 17: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Revenue ($m), USD Actual, Historic, 2003-2010 31
Figure 18: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Revenue ($m), USD Actual, Forecast, 2010-2017 32
Figure 19: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment,
Historic, 2003-2010 33
Figure 20: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment,
Forecast, 2010-2017 35
Figure 21: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Volume (Units), Historic, 2003-2010 37
Figure 22: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea,
Volume (Units), Forecast, 2010-2017 38
Figure 23: Glucose Monitoring, Republic of Korea, Company share (%), 2010 41
Figure 24: Insulin Delivery, Market Segmentation 43
Figure 25: Insulin Delivery Market, Republic of Korea, Revenue Mix ($m), 2010 44
Figure 26: Insulin Delivery Market, Republic of Korea, Segment Contribution (%),
2010 45
Figure 27: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 46
Figure 28: Insulin Delivery, Republic of Korea, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 48
Figure 29: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by
Sub-Segment, Historic, 2003-2010 50
Figure 30: Insulin Pens, Republic of Korea, Revenue ($m), USD Actual by
Sub-Segment, Forecast, 2010-2017 52
Figure 31: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue
($m), USD Actual, Historic, 2003-2010 54
Figure 32: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue
($m), USD Actual, Forecast, 2010-2017 55
Figure 33: Insulin Delivery, Republic of Korea, Volume (Units) by Segment,
Historic, 2003-2010 56
Figure 34: Insulin Delivery, Republic of Korea, Volume (Units) by Segment,
Forecast, 2010-2017 58
Figure 35: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment,
Historic, 2003-2010 60
Figure 36: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 62
Figure 37: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume
(Units), Historic, 2003-2010 64
Figure 38: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume
(Units), Forecast, 2010-2017 65
Figure 39: Insulin Delivery, Republic of Korea, Company share (%), 2010 68
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%),Republic of Korea
Diabetes Care Devices Market, 2010 70
Figure 41: LifeScan, Inc., Company Share (%),Republic of Korea Diabetes Care
Devices Market, 2010 71
Figure 42: Abbott Laboratories, Company Share (%),Republic of Korea Diabetes
Care Devices Market, 2010 72
Figure 43: Novo Nordisk A/S, Company Share (%),Republic of Korea Diabetes Care
Devices Market, 2010 73
Figure 44: Sanofi, Company Share (%),Republic of Korea Diabetes Care Devices
Market, 2010 74
Figure 45: Eli Lilly and Company, Company Share (%),Republic of Korea Diabetes
Care Devices Market, 2010 75
Companies Mentioned
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Abbott Laboratories
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
ARKRAY, Inc.
Bayer HealthCare AG
Terumo Corporation
Becton, Dickinson and Company
Apex Biotechnology Corp.
NIPRO CORPORATION
Medtronic, Inc.
Animas Corporation |
